Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
CD70
Name:
CD70 molecule
Location:
19p13.3
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT04227847 | A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies | View | |
| NCT02830724 | Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers | View | |
| NCT06345027 | Chimeric Antigen Receptor Treatment Targeting CD70 SEVENTY | View | |
| NCT01015911 | A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma | View | |
| NCT01677390 | A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma | View | |
| NCT05206045 | Evolution of the SURvival of Patients With SEzary Syndrome SS Over the 1998-2020 Period and Its Association With the Early Use of Therapeutic Monoclonal Antibodies | View | |
| NCT01813539 | A Study of ARGX-110 in Participants With Advanced Malignancies | View | |
| NCT04150887 | Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia | View | |
| NCT02888756 | iHIVARNA Clinical Trial in HIV Infected Individuals | View | |
| NCT05948033 | CD70 Targeted CAR-T Cells in CD70 Positive RelapsedRefractory Lymphoma | View | |
| NCT03125577 | Combination CAR-T Cell Therapy Targeting Hematological Malignancies | View | |
| NCT04429438 | Multi-CAR-T Cells Targeting B Cell Lymphomas | View | |
| NCT04662294 | CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases | View | |
| NCT05673057 | Study of MP0533 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome | View | |
| NCT06586658 | Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or RelapsedMetastatic CD70 Inoperable Renal Cells | View | |
| NCT04502446 | A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies COBALT-LYM | View | |
| NCT06326463 | CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies | View | |
| NCT05353530 | Phase I Study of IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70 Adult Glioblastoma IMPACT | View | |
| NCT05436496 | CD1970 Bi-specific CAR-T Cell Therapy | View | |
| NCT05437341 | PSMACD70 Bi-specific CAR-T Cell Therapy | View | |
| NCT05438368 | GD2CD70 Bi-specific CAR-T Cell Therapy | View | |
| NCT05468190 | A Clinical Research About CD70-positive AdvancedMetastatic Solid Tumors Treated by CD70-targeted CAR-T | View | |
| NCT05518253 | A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive AdvancedMetastatic Solid Tumors | View | |
| NCT05795595 | A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors | View | |
| NCT05947487 | CD70 Targeted CAR-T Cells in CD70 Positive AdvancedMetastatic Solid Tumors | View | |
| NCT05990621 | Anti-CD70 CAR-T Cell Injection in Patients With CD70-positive Advanced Urologic Neoplasms | View | |
| NCT06010875 | A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive AdvancedMetastatic Solid Tumors | View | |
| NCT06148220 | A Study of the Clinical Application of 18FRCCB6 and 68GaGa-NOTA-RCCB6 PETCT Imaging in the Diagnosis of CD70-expressing Multiple Tumors | View | |
| NCT06182735 | CD70-targeted CAR-NKT CellsCGC729 Therapy in the Renal Cell Carcinoma | View | |
| NCT06215950 | A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive AdvancedMetastatic Gynecologic Cancer | View | |
| NCT06383507 | A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors | View | |
| NCT06394622 | A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors | View | |
| NCT06480565 | A Phase 12 Trial of ADI-270 in ccRCC | View | |
| NCT06492304 | A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With RelapsedRefractory Hematologic Malignancies | View | |
| NCT05420519 | Clinical Study of CD70-targeted CAR-T Therapy for AdvancedAdvanced Renal Cancer | View | |
| NCT05420545 | A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive AdvancedMetastatic Solid Tumors | View | |
| NCT02216890 | Safety Study of SGN-CD70A in Cancer Patients | View | |
| NCT03407859 | Sequential Treatment With CD20CD22CD10-CART After CD19-CART Treatment Base on MRD in RelapsedRefractory B-ALL | View |